Harrow Health, Inc.HROWNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+38.8%
5Y CAGR+36.3%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+38.8%/yr
vs +11.3%/yr prior
5Y CAGR
+36.3%/yr
Consistent
Acceleration
+27.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$67.93M+38.0%
2024$49.24M+24.2%
2023$39.64M+56.2%
2022$25.38M+39.4%
2021$18.21M+25.9%
2020$14.46M-13.6%
2019$16.75M+1.4%
2018$16.52M+22.3%
2017$13.51M+37.4%
2016$9.83M-